Quotient Ltd (NASDAQ:QTNT) Q4 2017 Sentiment Report

May 27, 2018 - By Clifton Ray

Quotient Limited (NASDAQ:QTNT) Logo

Sentiment for Quotient Ltd (NASDAQ:QTNT)

Quotient Ltd (NASDAQ:QTNT) institutional sentiment increased to 1.93 in 2017 Q4. Its up 0.51, from 1.42 in 2017Q3. The ratio improved, as 29 investment professionals increased and started new equity positions, while 15 cut down and sold their stakes in Quotient Ltd. The investment professionals in our partner’s database now possess: 30.23 million shares, up from 21.37 million shares in 2017Q3. Also, the number of investment professionals holding Quotient Ltd in their top 10 equity positions decreased from 2 to 1 for a decrease of 1. Sold All: 5 Reduced: 10 Increased: 22 New Position: 7.

Quotient Limited, a commercial-stage diagnostics company, develops, makes, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company has market cap of $310.00 million. The firm is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening. It currently has negative earnings. It also develops, makes, and commercializes conventional reagent products for blood grouping, including antisera products that are used to identify blood-group antigens; reagent red blood cells, which enable the identification of blood-group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping.

The stock increased 3.98% or $0.26 during the last trading session, reaching $6.8. About 977,014 shares traded or 119.62% up from the average. Quotient Limited (NASDAQ:QTNT) has declined 24.44% since May 27, 2017 and is downtrending. It has underperformed by 35.99% the S&P500.

Analysts await Quotient Limited (NASDAQ:QTNT) to report earnings on May, 28. They expect $-0.51 earnings per share, up 26.09 % or $0.18 from last year’s $-0.69 per share. After $-0.47 actual earnings per share reported by Quotient Limited for the previous quarter, Wall Street now forecasts 8.51 % negative EPS growth.

Sio Capital Management Llc holds 3.98% of its portfolio in Quotient Limited for 1.43 million shares. Cormorant Asset Management Llc owns 4.49 million shares or 2.33% of their US portfolio. Moreover, Perceptive Advisors Llc has 0.98% invested in the company for 6.03 million shares. The Maryland-based Clearbridge Llc has invested 0.26% in the stock. Polar Capital Llp, a United Kingdom-based fund reported 6.80 million shares.

Since January 1, 0001, it had 1 insider purchase, and 0 sales for $51,348 activity.

More important recent Quotient Limited (NASDAQ:QTNT) news were published by: Streetinsider.com which released: “After-Hours Stock Movers 05/17: (QTNT) (VJET) (AFSI) Higher; (ARQL) (JWN) (AMAT) Lower (more…)” on May 17, 2018, also Globenewswire.com published article titled: “Quotient Limited Reports Commencement of EU Blood Grouping Field Trial”, Streetinsider.com published: “Quotient (QTNT) Commences EU Blood Grouping Field Trial” on May 17, 2018. More interesting news about Quotient Limited (NASDAQ:QTNT) was released by: Seekingalpha.com and their article: “Quotient Limited: Buy This Industry Disruptor” with publication date: May 21, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.